Efficacy of Compound Kushen Injection in Relieving Cancer-Related Pain: A Systematic Review and Meta-Analysis

Abstract EN

Despite widespread popular use of complementary and alternative medicine (CAM) therapies, a rigorous evidence based on the efficacy of compound kushen injection (CKI) for cancer-related pain is lacking.

In this study, we evaluated the efficacy and safety of compound kushen injection and provided information for current or future research and clinical application.

Sixteen trials were identified with a total of 1564 patients.

The total pain relief rate of CKI plus chemotherapy is better than chemotherapy except for colorectal cancer.

The treatment groups achieved a reduction in the incidences of leukopenia and gastrointestinal, hepatic, and renal functional lesion.

However, there is paucity of multi-institutional RCTs evaluating compound kushen injection for cancer pain with adequate power, duration, and sham control.

The quantity and quality of RCTs are lower so that we still have to boost the research level through scientific design and normative report.